Suzanne Gilboa, PhD
Acting Director, Division of Birth Defects and Infant Disorders
Dr. Gilboa is an Epidemiologist and acting Director of the Division of Birth Defects and Infant Disorders. She has been at CDC for 15 years and has served as a staff scientist, team lead, and Branch senior scientist. Dr. Gilboa has a longstanding interest in birth defects surveillance and research, with a focus on modifiable risk factors during pregnancy including environmental and occupational hazards, medication use, infections, substance use, and chronic medical conditions. She has extensive experience in emergency response, serving in long-term leadership roles on the 2016 CDC Zika Virus Response and the CDC COVID-19 Response. Dr. Gilboa serves as Co-Principal Investigator of the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), which currently supports nearly 30 state, local and territorial health departments to conduct mother-baby linked longitudinal surveillance for Zika, hepatitis C, syphilis and COVID-19. She is also a senior advisor for the Maternal and Infant Network to Understand Outcomes Associated with Treatment for Opioid Use Disorder during Pregnancy (MAT-LINK), a project funded by the Assistant Secretary for Planning and Evaluation’s Patient-Centered Outcomes Research Trust Fund, to support clinical sites for surveillance to improve our understanding of the range of maternal, infant, and child health outcomes associated with treatment for opioid use disorder during pregnancy. Dr. Gilboa served as a Peace Corps Volunteer in Nicaragua, and has a Masters in Health Science degree in Population and Family Health Sciences from The Johns Hopkins Bloomberg School of Public Health and her PhD in Epidemiology from the University of North Carolina at Chapel Hill Gillings School of Global Public Health.